0000028823-26-000008
SEC filingDiebold Nixdorf reported total revenues of $3.81 billion for fiscal year 2025, generating gross profit of $961.2 million and operating profit of $242.0 million. The company achieved net income attributable to Diebold Nixdorf of $94.6 million, with basic and diluted earnings per share of $3.00. Operating cash flow was strong at $300.7 million, while investing activities used $97.6 million primarily for capital expenditures and acquisitions, and financing activities used $143.9 million mainly for treasury share activity and distributions. The balance sheet shows total assets of $3.85 billion, with current assets of $1.79 billion and current liabilities of $1.37 billion, resulting in total equity of $1.10 billion. Long-term debt stood at $938.5 million, with cash and equivalents of $387.3 million providing liquidity.
Diebold Nixdorf reported total revenues of $3.81 billion for fiscal year 2025, with total cost of sales of $2.84 billion resulting in gross profit of $961.2 million. Operating expenses totaled $719.2 million, comprising selling and administrative expenses of $632.5 million and research, development and engineering expenses of $86.7 million. This yielded operating profit of $242.0 million. After interest expense of $85.7 million, foreign exchange losses of $44.1 million, and income tax expense of $24.1 million, the company reported net income of $97.5 million. Net income attributable to Diebold Nixdorf was $94.6 million, with basic and diluted earnings per share of $3.00 based on 36.8 million and 37.2 million weighted-average shares outstanding, respectively.
The filing provides consolidated revenue figures without segment or geographic breakdown. Total revenues of $3.81 billion represent the company's combined performance across all business activities. No specific revenue drivers, product/service mix, or geographic distribution details are disclosed in the provided data. The absence of segment reporting suggests the company may operate as a single reporting unit or that segment data was not included in this excerpt of the filing.
Gross margin was 25.2%, calculated from gross profit of $961.2 million on total revenues of $3.81 billion. Operating margin was 6.4%, derived from operating profit of $242.0 million. The cost structure shows selling and administrative expenses representing 16.6% of revenues, while research, development and engineering expenses accounted for 2.3% of revenues. No impairment charges were recorded during the period. Interest expense of $85.7 million exceeded interest income of $8.9 million, resulting in net interest expense that reduced pre-tax income.
Operating activities generated $300.7 million in cash, driven by net income of $97.5 million adjusted for non-cash items including depreciation and amortization of $127.5 million and deferred income taxes of $48.1 million. Investing activities used $97.6 million, primarily for capital expenditures of $37.4 million, capitalized software development of $24.3 million, and net payments for acquisitions of $24.5 million. Financing activities used $143.9 million, mainly for treasury share activity of $130.7 million and distributions to noncontrolling interest holders of $7.3 million. The balance sheet shows total assets of $3.85 billion, including current assets of $1.79 billion with trade receivables of $609.4 million and inventories of $521.0 million. Total liabilities were $2.75 billion, including current liabilities of $1.37 billion and long-term debt of $938.5 million. Total equity was $1.10 billion, with retained earnings of $91.9 million.
The provided data does not include management guidance, strategic priorities, or specific risk factors from the filing. No forward-looking statements, growth projections, or operational targets are disclosed in the extracted financial statements. Investors should refer to the complete 10-K filing for management's discussion and analysis, which typically contains outlook information, strategic initiatives, and risk factor disclosures required by SEC regulations.